189 related articles for article (PubMed ID: 27139475)
1. Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.
Srinivasan P; Zhang J; Martin A; Kelley K; McNicholl JM; Buckheit RW; Smith JM; Ham AS
Antimicrob Agents Chemother; 2016 Jul; 60(7):4140-50. PubMed ID: 27139475
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.
Pereira LE; Mesquita PM; Ham A; Singletary T; Deyounks F; Martin A; McNicholl J; Buckheit KW; Buckheit RW; Smith JM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1393-400. PubMed ID: 26666935
[TBL] [Abstract][Full Text] [Related]
3. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.
Johnson TJ; Srinivasan P; Albright TH; Watson-Buckheit K; Rabe L; Martin A; Pau CP; Hendry RM; Otten R; McNicholl J; Buckheit R; Smith J; Kiser PF
Antimicrob Agents Chemother; 2012 Mar; 56(3):1291-9. PubMed ID: 22155820
[TBL] [Abstract][Full Text] [Related]
4. Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.
Ham AS; Rohan LC; Boczar A; Yang L; W Buckheit K; Buckheit RW
Pharm Res; 2012 Jul; 29(7):1897-907. PubMed ID: 22392331
[TBL] [Abstract][Full Text] [Related]
5. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.
Su JT; Teller RS; Srinivasan P; Zhang J; Martin A; Sung S; Smith JM; Kiser PF
Pharm Res; 2017 Oct; 34(10):2163-2171. PubMed ID: 28770490
[TBL] [Abstract][Full Text] [Related]
6. Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.
Pereira LE; Singletary T; Martin A; Dinh CT; Deyounks F; Holder A; McNicholl J; Buckheit KW; Buckheit RW; Ham A; Katz DF; Smith JM
Drug Deliv Transl Res; 2018 Oct; 8(5):1180-1190. PubMed ID: 29761350
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles-in-film for the combined vaginal delivery of anti-HIV microbicide drugs.
Cunha-Reis C; Machado A; Barreiros L; Araújo F; Nunes R; Seabra V; Ferreira D; Segundo MA; Sarmento B; das Neves J
J Control Release; 2016 Dec; 243():43-53. PubMed ID: 27664327
[TBL] [Abstract][Full Text] [Related]
8. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
Mahalingam A; Simmons AP; Ugaonkar SR; Watson KM; Dezzutti CS; Rohan LC; Buckheit RW; Kiser PF
Antimicrob Agents Chemother; 2011 Apr; 55(4):1650-60. PubMed ID: 21245437
[TBL] [Abstract][Full Text] [Related]
9. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model.
Destache CJ; Mandal S; Yuan Z; Kang G; Date AA; Lu W; Shibata A; Pham R; Bruck P; Rezich M; Zhou Y; Vivekanandan R; Fletcher CV; Li Q
Antimicrob Agents Chemother; 2016 Jun; 60(6):3633-9. PubMed ID: 27044548
[TBL] [Abstract][Full Text] [Related]
10. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B).
Robinson JA; Marzinke MA; Bakshi RP; Fuchs EJ; Radebaugh CL; Aung W; Spiegel HM; Coleman JS; Rohan LC; Hendrix CW
AIDS Res Hum Retroviruses; 2017 Apr; 33(4):339-346. PubMed ID: 27809557
[TBL] [Abstract][Full Text] [Related]
12. The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques.
Cole AM; Patton DL; Rohan LC; Cole AL; Cosgrove-Sweeney Y; Rogers NA; Ratner D; Sassi AB; Lackman-Smith C; Tarwater P; Ramratnam B; Ruchala P; Lehrer RI; Waring AJ; Gupta P
PLoS One; 2010 Nov; 5(11):e15111. PubMed ID: 21124745
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Based ARV Drug Combinations for Synergistic Inhibition of Cell-Free and Cell-Cell HIV Transmission.
Jiang Y; Cao S; Bright DK; Bever AM; Blakney AK; Suydam IT; Woodrow KA
Mol Pharm; 2015 Dec; 12(12):4363-74. PubMed ID: 26529558
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques.
Dobard CW; Sharma S; Cong ME; West R; Makarova N; Holder A; Pau CP; Hanson DL; Novembre FJ; Garcia-Lerma JG; Heneine W
Retrovirology; 2015 Aug; 12():69. PubMed ID: 26253002
[TBL] [Abstract][Full Text] [Related]
15. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.
Ugaonkar SR; Clark JT; English LB; Johnson TJ; Buckheit KW; Bahde RJ; Appella DH; Buckheit RW; Kiser PF
J Pharm Sci; 2015 Oct; 104(10):3426-39. PubMed ID: 26149293
[TBL] [Abstract][Full Text] [Related]
16. Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa.
Rastogi R; Teller RS; Mesquita PM; Herold BC; Kiser PF
Antiviral Res; 2013 Oct; 100(1):255-8. PubMed ID: 23973812
[TBL] [Abstract][Full Text] [Related]
17. A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film.
Bunge KE; Dezzutti CS; Rohan LC; Hendrix CW; Marzinke MA; Richardson-Harman N; Moncla BJ; Devlin B; Meyn LA; Spiegel HM; Hillier SL
J Acquir Immune Defic Syndr; 2016 Apr; 71(5):498-505. PubMed ID: 26565716
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.
Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM
Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245
[TBL] [Abstract][Full Text] [Related]
19. Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study.
Al-Khouja A; Shieh E; Fuchs EJ; Marzinke MA; Bakshi RP; Hummert P; Ham AS; Buckheit KW; Breakey J; Weld ED; Chen H; Caffo BS; Buckheit RW; Hendrix CW
AIDS Res Hum Retroviruses; 2021 Jun; 37(6):444-452. PubMed ID: 33371779
[TBL] [Abstract][Full Text] [Related]
20. Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.
Stolte-Leeb N; Loddo R; Antimisiaris S; Schultheiss T; Sauermann U; Franz M; Mourtas S; Parsy C; Storer R; La Colla P; Stahl-Hennig C
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):933-43. PubMed ID: 21332419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
